Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30 | 70 | 70 | 20 | 20 |
| Receivables | 0 | 0 | 0 | 1 | 0 |
| Other current assets | 20 | 30 | 40 | 19 | 20 |
| TOTAL | $50 | $100 | $110 | $40 | $40 |
| Non-Current Assets | |||||
| PPE Net | 140 | 60 | 140 | 130 | 110 |
| Other Non-Current Assets | 220 | 400 | 210 | 210 | 210 |
| TOTAL | $360 | $460 | $350 | $340 | $320 |
| Total Assets | $320 | $360 | $390 | $300 | $290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 40 | 0 | 10 | 7 | 990 |
| Accrued Expenses | 530 | 210 | 580 | 560 | 540 |
| Other current liabilities | 10 | 430 | 7 | 10 | 240 |
| TOTAL | $1,670 | $1,830 | $1,750 | $1,730 | $3,480 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,670 | $1,830 | $1,750 | $1,730 | $3,480 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 50 | 50 |
| Retained earnings | -29,240 | -28,770 | -28,080 | -26,910 | -26,220 |
| Other shareholders' equity | 20 | 10 | 0 | 0 | 10 |
| TOTAL | $-1,340 | $-1,460 | $-1,360 | $-1,430 | $-3,180 |
| Total Liabilities And Equity | $330 | $370 | $390 | $300 | $300 |